Kyle P. Chiang

2.2k citations

25 papers · 1.7k indexed · h-index 20

Molecular Biology top 10%
Pharmacology top 2%
Organic Chemistry top 10%
Cellular and Molecular Neuroscience top 10%
Physiology top 10%

Co-authors: Benjamin F. Cravatt Jack C. Sipe Ernest Beutler Alexandra Lehmkuhl Gerber Jeffery W. Kelly Evan T. Powers Hans E. Purkey Tom W. Muir
Topics: RNA Research and Splicing (6 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers)Alzheimer's disease research and treatments (4 papers)
Cited by: Pharmacology Toxicology Cellular and Molecular Neuroscience
Journals: Science Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Hong Kong Germany

In The Last Decade

Kyle P. Chiang

25 papers receiving 1.7k citations

Peers

Countries citing papers authored by Kyle P. Chiang

Since Specialization

Citations

This map shows the geographic impact of Kyle P. Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle P. Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle P. Chiang more than expected).

Fields of papers citing papers by Kyle P. Chiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle P. Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle P. Chiang. The network helps show where Kyle P. Chiang may publish in the future.

Co-authorship network of co-authors of Kyle P. Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle P. Chiang. A scholar is included among the top collaborators of Kyle P. Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle P. Chiang. Kyle P. Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia 2022 ·PLoS ONE ·Shengwen Zhang,(unknown),Susana Gordo,(unknown),(unknown),Elizabeth A. McCarthy,Xiaohan Zhang,(unknown),Chih‐Wei Ko,(unknown),(unknown),(unknown),(unknown),Qiang Xiong,Lauren M. Drouin,Matthias Hebben,Kyle P. Chiang,(unknown)	5
2	Promoterless, Nuclease‐Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia 2020 ·Hepatology ·Randy J. Chandler,(unknown),(unknown),Brandon T. Hubbard,Jessica L. Schneller,Victoria Hoffmann,Susana Gordo,(unknown),Chih‐Wei Ko,Nelson Chau,Kyle P. Chiang,Mark A. Kay,Adi Barzel,Charles P. Venditti	43
3	Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses 2019 ·Cellular and Molecular Immunology ·Ryan A. Adams,Cátia Fernandes‐Cerqueira,Antonella Notarnicola,Elisabeth Mertsching,Zhiwen Xu,Wing‐Sze Lo,Kathleen M. Ogilvie,Kyle P. Chiang,Jeanette Ampudia,Sanna Rosengren,(unknown),David J. King,John Mendlein,Xiang‐Lei Yang,Leslie A. Nangle,Ingrid E. Lundberg,Per‐Johan Jakobsson,Paul Schimmel	26
4	A randomized, double-blinded, placebo-controlled, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and biological activity of ATYR1940 in adult patients with facioscapulohumeral muscular dystrophy (FSHD) 2016 ·Neuromuscular Disorders ·A.B. Gershman,Kyle P. Chiang,(unknown),Evertine J. Abbink,(unknown),Christine Audebert,(unknown),Mauro Monforte,Stanley Iyadurai,Leeanne M. Carey,Linda Heskamp,Hermien E. Kan,Arend Heerschap,J. T. Kissel,Enzo Ricci,(unknown),(unknown),John Mendlein,Melissa A. Ashlock	7
5	Human tRNA synthetase catalytic nulls with diverse functions 2014 ·Science ·Wing‐Sze Lo,Elisabeth Gardiner,Zhiwen Xu,(unknown),Feng Wang,Jie Zhou,John Mendlein,Leslie A. Nangle,Kyle P. Chiang,Xiang‐Lei Yang,(unknown),Wing Hung Wong,Min Guo,Mingjie Zhang,Paul Schimmel	91
6	Secreted Histidyl-tRNA Synthetase Splice Variants Elaborate Major Epitopes for Autoantibodies in Inflammatory Myositis 2014 ·Journal of Biological Chemistry ·Jie Zhou,Feng Wang,Zhiwen Xu,Wing‐Sze Lo,(unknown),Kyle P. Chiang,Leslie A. Nangle,Melissa A. Ashlock,John Mendlein,Xiang‐Lei Yang,Mingjie Zhang,Paul Schimmel	42
7	Internally Deleted Human tRNA Synthetase Suggests Evolutionary Pressure for Repurposing 2012 ·Structure ·Zhiwen Xu,Zhiyi Wei,Jie Zhou,Fei Ye,Wing‐Sze Lo,Feng Wang,(unknown),Jingjing Wu,Leslie A. Nangle,Kyle P. Chiang,Xiang‐Lei Yang,Mingjie Zhang,Paul Schimmel	26
8	Cholesteryl ester hydrolase activity is abolished in HSL macrophages but unchanged in macrophages lacking KIAA1363 2010 ·Journal of Lipid Research ·(unknown),Thomas Pfeifer,(unknown),Prakash G. Chandak,Achim Lass,Renate Schreiber,Adelheid Kratzer,Robert Zimmermann,Wolfgang Sattler,Harald Koefeler,Eleonore Fröhlich,Gerhard M. Kostner,Ruth Birner‐Gruenberger,Kyle P. Chiang,Guenter Haemmerle,Rudolf Zechner,Sanja Levak‐Frank,Benjamin F. Cravatt,Dagmar Kratky	42
9	Direct Measurement of Cathepsin B Activity in the Cytosol of Apoptotic Cells by an Activity-Based Probe 2009 ·Chemistry & Biology ·Matthew R. Pratt,Matthew D. Sekedat,Kyle P. Chiang,Tom W. Muir	32
10	A Semisynthetic Strategy to Generate Phosphorylated and Acetylated Histone H2B 2009 ·ChemBioChem ·Kyle P. Chiang,Mette S. Jensen,Robert K. McGinty,Tom W. Muir	55
11	Systems- and Molecular-Level Elucidation of Signaling Processes Through Chemistry 2008 ·Science Signaling ·Kyle P. Chiang,Tom W. Muir	2
12	An Enzyme that Regulates Ether Lipid Signaling Pathways in Cancer Annotated by Multidimensional Profiling 2006 ·Chemistry & Biology ·Kyle P. Chiang,Sherry Niessen,Alan Saghatelian,Benjamin F. Cravatt	162
13	Serine Hydrolase KIAA1363: Toxicological and Structural Features with Emphasis on Organophosphate Interactions 2006 ·Chemical Research in Toxicology ·Daniel K. Nomura,Kathleen A. Durkin,Kyle P. Chiang,Gary B. Quistad,Benjamin F. Cravatt,John E. Casida	27
14	Design, synthesis, and evaluation of oxazole transthyretin amyloidogenesis inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Hossein Razavi,Evan T. Powers,Hans E. Purkey,Sara L. Adamski‐Werner,Kyle P. Chiang,(unknown),Jeffery W. Kelly	42
15	A brain detoxifying enzyme for organophosphorus nerve poisons 2005 ·Proceedings of the National Academy of Sciences ·Daniel K. Nomura,Donmienne Leung,Kyle P. Chiang,Gary B. Quistad,Benjamin F. Cravatt,John E. Casida	42
16	Potent and Selective Structure-Based Dibenzofuran Inhibitors of Transthyretin Amyloidogenesis: Kinetic Stabilization of the Native State 2005 ·Journal of the American Chemical Society ·H. Michael Petrassi,Steven M. Johnson,Hans E. Purkey,Kyle P. Chiang,(unknown),Xin Jiang,Evan T. Powers,Jeffery W. Kelly	61
17	Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use 2004 ·Human Molecular Genetics ·Kyle P. Chiang	223
18	Benzoxazoles as Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of Action 2003 ·Angewandte Chemie International Edition ·Hossein Razavi,S.K. Palaninathan,Evan T. Powers,R. Luke Wiseman,Hans E. Purkey,Nilofar N. Mohamedmohaideen,Songpon Deechongkit,Kyle P. Chiang,(unknown),James C. Sacchettini,Jeffery W. Kelly	200
19	Benzoxazoles as Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation, and Mechanism of Action 2003 ·Angewandte Chemie ·Hossein Razavi,S.K. Palaninathan,Evan T. Powers,R. Luke Wiseman,Hans E. Purkey,Nilofar N. Mohamedmohaideen,Songpon Deechongkit,Kyle P. Chiang,(unknown),James C. Sacchettini,Jeffery W. Kelly	37
20	Synthesis, Structure, and Activity of Diclofenac Analogues as Transthyretin Amyloid Fibril Formation Inhibitors 2001 ·Journal of Medicinal Chemistry ·Vibha Oza,(unknown),Prakash Raman,Edward K. Koepf,Hilal A. Lashuel,(unknown),Kyle P. Chiang,Evan T. Powers,(unknown),Jeffery W. Kelly	109

About Kyle P. Chiang

Kyle P. Chiang is a scholar working on Toxicology, Molecular Biology and Physiology, having authored 25 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA Research and Splicing (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Alzheimer's disease research and treatments (4 papers). The work is most often cited by research in Pharmacology (511 citations), Toxicology (50 citations) and Cellular and Molecular Neuroscience (257 citations). Kyle P. Chiang has collaborated with scholars based in United States, Hong Kong and Germany. Frequent co-authors include Benjamin F. Cravatt, Jack C. Sipe, Ernest Beutler, Alexandra Lehmkuhl Gerber, Jeffery W. Kelly, Evan T. Powers, Hans E. Purkey, Tom W. Muir, Sherry Niessen and Alan Saghatelian. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact